COVID-19 vaccine (BNT162b2, with BioNTech)

URI: https://gptkb.org/entity/COVID-19_vaccine_(BNT162b2,_with_BioNTech)
GPTKB entity
Statements (53)
Predicate Object
gptkbp:instanceOf vaccine
gptkbp:age 12 years and older
gptkbp:alsoKnownAs gptkb:Pfizer-BioNTech_COVID-19_vaccine
gptkbp:antigen gptkb:SARS-CoV-2_spike_protein
gptkbp:approvedBy gptkb:World_Health_Organization
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration
gptkbp:ATCCode gptkb:J07BX03
gptkbp:boosterDoseAvailable yes
gptkbp:clinicalTrialPhase 2020
gptkbp:contains sodium chloride
potassium chloride
saline
sucrose
lipid nanoparticles
water for injection
dibasic sodium phosphate dihydrate
monobasic potassium phosphate
nucleoside-modified mRNA
gptkbp:contraindication severe allergic reaction to any component
gptkbp:developedBy gptkb:Pfizer
gptkb:BioNTech
gptkbp:efficacyAgainstOriginalStrain ~95%
gptkbp:emergencyServices gptkb:European_Union
gptkb:United_States
gptkbp:emergencyUseAuthorizationDate 2020-12-11
gptkbp:form suspension for injection
gptkbp:fullFDAApprovalDate 2021-08-23
https://www.w3.org/2000/01/rdf-schema#label COVID-19 vaccine (BNT162b2, with BioNTech)
gptkbp:indication prevention of COVID-19
gptkbp:initialApprovalCountry gptkb:United_Kingdom
gptkbp:initialApprovalDate 2020-12-02
gptkbp:KEGGID D12020
gptkbp:legalStatus prescription only
gptkbp:marketedAs gptkb:Comirnaty
gptkbp:MedlinePlusID a621006
gptkbp:numberOfDoses 2
gptkbp:pregnancyCategory consult healthcare provider
gptkbp:PubChem_CID 155903259
DB16461
gptkbp:routeOfAdministration intramuscular injection
gptkbp:sideEffect fever
fatigue
headache
muscle pain
chills
pain at injection site
gptkbp:storage -70°C
gptkbp:technology vaccine
gptkbp:UNII 5085ZFP6SJ
gptkbp:WHOEmergencyUseListing 2020-12-31
gptkbp:bfsParent gptkb:Fosun_Pharma
gptkbp:bfsLayer 6